Sermorelin Before and After: What Results Actually Look Like at 3, 6, and 12 Months Sermorelin before and after results are one of the most searched topics in GH-releasing peptide therapy, and for good reason: the timeline is specific enough to be useful, and the results are variable enough that understanding what drives them matters
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
MariTide Name: Maridebart cafraglutide (MariTide, formerly AMG 133) Manufacturer: Amgen Current stage: US phase III trial currently underway (MARITIME, NCT06858839) Takeaway: The dual agonist/antagonist action of MariTide could promise higher weight loss with fewer side effects, with dosing at less frequent intervals but more studies are needed
13 In a third case, a 50-year-old female patient with obesity and T2DM was started on semaglutide (0.25mg per week x 4 weeks, then 0.5mg per week x 12 weeks, maintained on 1mg per week) and evaluated for changes in adipose tissue depots surrounding the heart and coronary arteries